It is well-known that TGF-β promotes collagen synthesis, secretion, processing, and cross-linking as well as secretion of other matrix molecules, such as fibronectin and thrombospondin.41 This has led to an interest in using anti-TGF-β in SSc. The gene discussed is TGFB1; the disease is systemic sclerosis.